MarketPulse
N

$NSRX

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nasus Pharma CEO to Present Pipeline at Three Major Healthcare Conferences

Nasus Pharma CEO presents clinical pipeline at three major healthcare conferences in February-March, showcasing NS002 intranasal epinephrine for anaphylaxis treatment.
NSRXclinical-stageinvestor conference
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nasus Pharma Closes $15M Capital Raise to Fund Epinephrine Product Development

Nasus Pharma raises $15M to advance intranasal epinephrine product toward FDA trials. Funds support NS002 development and pipeline expansion.
NSRXprivate placementcapital raise